Guy Miller

1.2k total citations
27 papers, 945 citations indexed

About

Guy Miller is a scholar working on Molecular Biology, Clinical Biochemistry and Biochemistry. According to data from OpenAlex, Guy Miller has authored 27 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Clinical Biochemistry and 4 papers in Biochemistry. Recurrent topics in Guy Miller's work include Mitochondrial Function and Pathology (12 papers), ATP Synthase and ATPases Research (5 papers) and Metabolism and Genetic Disorders (5 papers). Guy Miller is often cited by papers focused on Mitochondrial Function and Pathology (12 papers), ATP Synthase and ATPases Research (5 papers) and Metabolism and Genetic Disorders (5 papers). Guy Miller collaborates with scholars based in United States, Italy and Brazil. Guy Miller's co-authors include William D. Shrader, Viktoria Kheifets, Martin Thoolen, Stephen D. Phinney, Jonathan Himmelfarb, Ellen McMonagle, Akiko Amagata, Gregory M. Enns, A. Scott Hinman and Matthew B. Klein and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Neurology.

In The Last Decade

Guy Miller

26 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy Miller United States 12 620 228 128 127 116 27 945
Toru Nishinaka Japan 22 769 1.2× 123 0.5× 45 0.4× 32 0.3× 43 0.4× 62 1.5k
Isabelle Escargueil‐Blanc France 16 593 1.0× 74 0.3× 80 0.6× 33 0.3× 32 0.3× 17 1.2k
Sampath Parthasarathy United States 10 257 0.4× 225 1.0× 165 1.3× 40 0.3× 25 0.2× 12 1.1k
Rita Roberti Italy 22 674 1.1× 143 0.6× 87 0.7× 59 0.5× 28 0.2× 72 1.1k
Sakthivel Muniyan United States 23 656 1.1× 51 0.2× 85 0.7× 21 0.2× 164 1.4× 53 1.2k
Ravinder Tammali United States 19 637 1.0× 121 0.5× 34 0.3× 19 0.1× 36 0.3× 34 1.2k
Veronica Fitzgerald United States 15 602 1.0× 156 0.7× 205 1.6× 42 0.3× 43 0.4× 23 1.1k
Tamás Kardon Hungary 17 386 0.6× 43 0.2× 100 0.8× 13 0.1× 189 1.6× 30 926
Ten‐ching Lee United States 21 754 1.2× 174 0.8× 187 1.5× 44 0.3× 51 0.4× 47 1.3k
Sung Ho Moon United States 16 610 1.0× 95 0.4× 66 0.5× 26 0.2× 24 0.2× 28 885

Countries citing papers authored by Guy Miller

Since Specialization
Citations

This map shows the geographic impact of Guy Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Miller more than expected).

Fields of papers citing papers by Guy Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Miller. The network helps show where Guy Miller may publish in the future.

Co-authorship network of co-authors of Guy Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Miller. A scholar is included among the top collaborators of Guy Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Miller. Guy Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davies, Sarah L., et al.. (2025). Defining the analytical characteristics of a novel high-sensitivity point-of-care troponin I assay in its intended clinical environment. Clinical Chemistry and Laboratory Medicine (CCLM). 64(1). 194–204.
2.
3.
Miller, Guy, et al.. (2022). Northward Expansion of Amblyomma americanum (Acari: Ixodidae) into Southwestern Michigan. Journal of Medical Entomology. 59(5). 1646–1659. 9 indexed citations
4.
Hinman, A. Scott, Charles R. Holst, Joey C. Latham, et al.. (2018). Vitamin E hydroquinone is an endogenous regulator of ferroptosis via redox control of 15-lipoxygenase. PLoS ONE. 13(8). e0201369–e0201369. 149 indexed citations
5.
Miyauchi, Akihiko, Hiroko Shimbo, Mizue Iai, et al.. (2017). Japanese Leigh syndrome case treated with EPI-743. Brain and Development. 40(2). 145–149. 19 indexed citations
6.
Karanjia, Rustum, Edward R. Chu, Rubens Belfort, et al.. (2016). EPI-743 (Quinone) therapy for Leber’s Hereditary Optic Neuropathy: the Brazil experience.. Investigative Ophthalmology & Visual Science. 57(12). 5084–5084. 1 indexed citations
7.
Zesiewicz, Theresa A., Israt Jahan, Jessica Shaw, et al.. (2016). EPI-743 Improves Motor Function and CNS Biomarkers in PD: Results from a Phase 2A Pilot Trial (S40.004). Neurology. 86(16_supplement). 1 indexed citations
8.
Zesiewicz, Theresa A., Israt Jahan, Jessica Shaw, et al.. (2016). EPI-743 Improves Motor Function and CNS Biomarkers in PD: Results from a Phase 2A Pilot Trial (I1.012). Neurology. 86(16_supplement). 3 indexed citations
9.
10.
Sullivan, Kelly L., Jessica Shaw, Clifton L. Gooch, et al.. (2016). EPI-743 for Friedreichs Ataxia Patients with Point Mutations (P5.388). Neurology. 86(16_supplement). 5 indexed citations
11.
Chu, Edward R., Rustum Karanjia, Rubens Belfort, et al.. (2014). EPI-743 May Improve Visual Acuity in LHON: Data from a Brazilian Cohort. Investigative Ophthalmology & Visual Science. 55(13). 6201–6201. 1 indexed citations
12.
Chicani, Carlos Filipe, Edward Chu, Fred N. Ross‐Cisneros, et al.. (2013). Treatment of Leber's hereditary optic neuropathy (LHON): Results using a novel quinone, EPI-743. Investigative Ophthalmology & Visual Science. 54(15). 4574–4574. 3 indexed citations
13.
Martinelli, Diego, Michela Catteruccia, Fiorella Piemonte, et al.. (2012). EPI-743 reverses the progression of the pediatric mitochondrial disease—Genetically defined Leigh Syndrome. Molecular Genetics and Metabolism. 107(3). 383–388. 149 indexed citations
14.
Blankenberg, Francis G., Stephen L. Kinsman, Bruce H. Cohen, et al.. (2012). Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI-743 in patients with mitochondrial disease. Molecular Genetics and Metabolism. 107(4). 690–699. 27 indexed citations
15.
Lynch, David R., Steven M. Willi, Robert B. Wilson, et al.. (2012). A0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trial. Movement Disorders. 27(8). 1026–1033. 66 indexed citations
16.
Enns, Gregory M., Stephen L. Kinsman, Susan Perlman, et al.. (2011). Initial experience in the treatment of inherited mitochondrial disease with EPI-743. Molecular Genetics and Metabolism. 105(1). 91–102. 148 indexed citations
17.
Shrader, William D., Akiko Amagata, Gregory M. Enns, et al.. (2011). α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging. Bioorganic & Medicinal Chemistry Letters. 21(12). 3693–3698. 70 indexed citations
18.
Himmelfarb, Jonathan, et al.. (2007). Gamma-Tocopherol and Docosahexaenoic Acid Decrease Inflammation in Dialysis Patients. Journal of Renal Nutrition. 17(5). 296–304. 85 indexed citations
19.
Himmelfarb, Jonathan, et al.. (2003). Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney International. 64(3). 978–991. 91 indexed citations
20.
Zou, Ying, et al.. (2002). Total Synthesis of Deamido Bleomycin A2, the Major Catabolite of the Antitumor Agent Bleomycin. Journal of the American Chemical Society. 124(32). 9476–9488. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toru Nishinaka Breakdown of academic impact, for papers by Isabelle Escargueil‐Blanc Breakdown of academic impact, for papers by Sampath Parthasarathy Breakdown of academic impact, for papers by Rita Roberti Breakdown of academic impact, for papers by Sakthivel Muniyan Breakdown of academic impact, for papers by Ravinder Tammali Breakdown of academic impact, for papers by Veronica Fitzgerald Breakdown of academic impact, for papers by Tamás Kardon Breakdown of academic impact, for papers by Ten‐ching Lee Breakdown of academic impact, for papers by Sung Ho Moon
Rankless by CCL
2026